Objective: To determine the proportion of women presenting for an induced abortion in Ghana who could use a gestational wheel to determine if they had reached at least 13 weeks or fewer than 13 weeks of pregnancy accurately.
| INTRODUCTION
Despite Ghana having relatively liberal laws surrounding induced abortion, evidence has demonstrated that the self-administration of misoprostol by women outside clinical settings is common practice. [1] [2] [3] Misoprostol alone, when administered according to the regimen recommended by WHO, is an effective medical abortion technique with a success rate of 85% for patients at up to 9 weeks of pregnancy. 4 Although there is limited evidence of the effectiveness of misoprostol for induced abortion of pregnancies at 9-13 weeks, WHO has endorsed using the evidence-based regimen for earlier than 9 weeks of pregnancy for pregnancies between 9 and 13 weeks. 5 Given the safety and simple administration of the regimen, arguments have been except in the event of treatment failure or adverse events. 6 The correct use of misoprostol depends on a patient being able to assess the duration of their pregnancy accurately to determine if the method can be used safely and effectively, as well as what regimen to use.
Anecdotal and empirical evidence has suggested that many
Ghanaian women self-administer misoprostol without clinical consultations, believing that they know the pregnancy duration in which the drug must be used and the length of their own pregnancy. 2 Given the estimated prevalence of misoprostol use outside clinical settings in Ghana, improved understanding of women's ability to date their pregnancies is critical to inform programmatic and political efforts to increase access to medical abortion outside health facilities. 1, 2 The option of performing medical abortions outside the clinical setting could potentially increase access to safe induced abortion and, consequently, contribute directly to a decrease in maternal morbidity and mortality.
The primary objective of the present study was to determine the proportion of a sample of women presenting at clinical facilities in
Ghana for an induced abortion who could use a gestational wheel to accurately determine whether their pregnancy had reached at least 13 weeks or was earlier than 13 weeks. The gestational wheel is a tool for calculating pregnancy length from an individual's last menstrual period (LMP). The cut-off point of 13 weeks of pregnancy was chosen to align with the WHO recommended regimen for the use of misoprostol alone during the first trimester. 5 Additional objectives included examining associations between women classified as having a "highrisk disagreement" with clinician-assessed pregnancy length (i.e., the patient dates her pregnancy as being earlier than 13 weeks and the clinician dates the pregnancy as at least 13 weeks) and potential correlates, and determining the extent to which women over-or underestimate pregnancy length.
| MATERIALS AND METHODS
The present cross-sectional, observational study enrolled women attending two public and two private health facilities in the Eastern were then asked to self-assess pregnancy length using a gestational wheel based on the self-reported date of their LMP (Fig. 1 ). The participant did not receive any verbal instruction on how to use the wheel. However, if a woman was unable to use the wheel without instruction, interviewers provided a verbal overview of how to use the gestational wheel before asking participants to try again.
Participants were also asked how easy they found the wheel to use.
Participants were not asked whether they had previously used a gestational wheel because this was considered highly unlikely in the study setting.
After the interview, a healthcare provider (typically a midwife)
confirmed the pregnancy and independently assessed the duration
of the pregnancy by clinical assessment and bimanual examination.
To reduce the potential for bias, study providers were masked to participants' own pregnancy-length assessments. In Ghana, the standard of care for pregnancy dating is through clinical history and bimanual examination; however, some women undergo ultrasonography examination or dating via abdominal palpation only. The study providers documented pregnancy lengths and key examination findings that could interfere with pregnancy dating, such as fibroids or multiple gestations (confirmed with ultrasonography), in a provider questionnaire; this was given to the on-site study interviewer immediately. To standardize pregnancy dating across study providers and sites prior to initiating the study, providers received refresher training on bimanual examination and estimating pregnancy length from an experienced obstetrician/gynecologist using the standard "fruit model"
that is typical used in correlating uterine size and pregnancy length.
Additionally, study providers were periodically observed during the study period by an external clinical consultant to ensure consistency in dating.
Participant and provider questionnaires were collected by the onsite study staff and stored in sealed envelopes in a locked file cabinet until retrieval by the study field coordinator. The field coordinator collected the completed participant files from the sites each month.
Data were entered into EpiData 3.1 (EpiData Association, Odense,
Denmark) and converted into Stata version 13 (StataCorp, College
Station, TX, USA) for analysis. Categorical data were expressed as absolute numbers and percentages, and continuous data were expressed as means and standard deviations. The analysis included all participants without missing data for the outcomes of interest.
Participants who had uterine fibroids or multiple gestations (both of which could have affected provider assessments of pregnancy length)
were excluded from the analyses.
The proportion of participants who could accurately determine if they were at earlier than 13 weeks of pregnancy or at least 13 weeks of pregnancy using a gestational wheel (based on self-reported LMP) was calculated. Provider data were used as reference standards and contingency tables were generated detailing the agreement between participants and providers in terms of pregnancy dating. The distribution of provider-determined pregnancy lengths for participants classified as having a high-risk disagreement with the study provider assessments was evaluated. Participants were classified as having a high-risk disagreement if they dated their pregnancy as earlier than 13 weeks but the provider dated it as at least 13 weeks. 
| RESULTS
There were 1282 women screened for participation in the study;
there were 415 patients deemed ineligible because they already knew the length of their pregnancy, because they had not completed formal primary education, or because they were younger than 18 years. Of the 867 eligible patients, 19 declined to participate, 63 women were excluded because they received abdominal palpation only, and five women were excluded owing to provider findings of multiple gestation (n=1), fibroids (n=2), no pregnancy (n=1), and spontaneous abortion in progress (n=1). Consequently, there were 780 patients included in the study. For the contingency tables and comparisons between agreement and risk groups, 766 patients were included owing to missing data for the reported "weeks pregnant" based on the wheel (n=4) or women not recalling their LMP (n=10).
The mean age of the participants was 25.46 ± 5.17 years and 474
(60.8%) were aged at least 24 years ( Similarly, self-reported ease of wheel use was also associated with educational attainment (P<0.001) and being able to read a newspaper (P<0.001).
Among the 770 patients with pregnancy-length estimates, agreement between participant-and study provider-evaluated pregnancy length was recorded for 728 (94.5%) participants. There were 10
(1.3%) participants who were classified as having low-risk disagreements with the provider assessment of pregnancy length and 28 (3.7%) participants had high-risk disagreements. Of the participants with high-risk disagreements, 16 (57%) were assessed as being at 13 or 14 weeks of pregnancy by the study providers; 11 were considered to be between 16 and 22 weeks of pregnancy and one participant was estimated to be at 28 weeks of pregnancy ( Table 2 ).
The only variables found to be associated with participants having high-risk disagreements with the provider-assessed pregnancy length were age (P=0.006), relationship status (P=0.002), ability to recall the exact date of the LMP (P<0.001), and the self-reported degree of certainty in reporting the LMP (P=0.002) ( Table 3) .
Of the 766 participants included in the analysis, 253 (33.0%)
women disagreed with the provider assessment of pregnancy length by longer than 1 week (either earlier or later) ( Table 4) ; 147 (19.2%) participants disagreed by longer than 2 weeks (either earlier or later).
The size of disagreements was stratified by the provider estimates; participant estimates appeared to be more accurate at earlier pregnancy durations (4-11 weeks of pregnancy), with the largest mean difference being an underestimate of 2 ± 2.18 weeks. Among later pregnancies (≥12 weeks), the participant estimates appeared to demonstrate greater differences with the provider estimates; among pregnancies at least 15 weeks in length (based on provider assessments), the mean difference in participant estimates was an underestimate of 6 ± 5.31 weeks.
| DISCUSSION
In the present study, a majority of participants reported being able to recall their LMP accurately and had a high degree of confidence in the level of accuracy. Among participants who reported being able to recall their LMP, all could use the gestational wheel to estimate the length of their pregnancy, although a majority required verbal instruction; a majority of the participants who used the wheel reported that it was easy to use. The participant-and provider-estimated pregnancy length were in agreement for 94.5% of participants and only 28 (3.6%)
participants were considered to have high-risk disagreements with the provider assessments. Generally, study participants underestimated their pregnancy length. These results are consistent with previous research. 6 Unfortunately, simply knowing their own LMP does not necessarily translate into a patient accurately (and independently) estimating pregnancy length.
For some, a simple tool that aids in translating LMP to pregnancy duration could prove helpful in decision making surrounding seeking a safe induced abortion. To understand the feasibility of such a tool, the ability of the present study cohort to use a gestational wheel to date pregnancies was assessed; this represents an important step in using misoprostol safely outside of a healthcare facility. With simple stepby-step instructions (written or verbal), all the participants that tried to use the wheel could do so (regardless of accuracy) and a majority found it easy. These findings were similar to those of a recent study 7 that examined the ability of patients to determine medical abortion eligibility and success in Nepal; the study reported that the gestational wheel was easy to use.
7
T with misoprostol-only induced abortion during the second trimester are low. 8, 9 Misoprostol-based regimens have been recommended for induced abortions at any pregnancy length but there are risks associated with misoprostol use in advanced pregnancy, including uterine rupture and hemorrhage. 5 Consequently, women undergoing medical abortions outside a clinical setting need to know when to administer drugs, to understand the signs and symptoms of adverse events or continuing pregnancy, and to know where they should seek follow-up care.
A potential limitation of the present study was related to the pregnancy-length limits for induced abortion provision among the study providers. All study providers were trained nurse midwives and, as per the Ghana comprehensive abortion care standards and protocols, 10 these clinicians can only provide comprehensive abortion care up to 12 weeks of pregnancy. Consequently, it could be suggested that the reason a majority of the study population could date their pregnancies at earlier than 13 weeks was existing knowledge of these restrictions and the need to present during early pregnancy. However, it has been well documented 11, 12 that patients and providers have limited understanding of abortion law in Ghana and that patients have limited awareness of these restrictions on service provision. Therefore, it is unlikely that most of the study population were aware of the pregnancy-duration limit and intentionally sought services prior to 13 weeks of pregnancy or purposely reported a LMP corresponding to a pregnancy length below 13 weeks. An additional limitation was the use of bimanual examination as the "gold standard" for comparison. In conclusion, educating patients and community members on the use of a gestational wheel or other similar tools could be a promising strategy for improving the safety of medical induced abortions performed outside the healthcare system. Further, community-based activities that increase women's knowledge of medical abortion eligibility and dosing, as well as their ability to accurately date pregnancies and recognize when to seek care, have the potential to increase access to safe induced abortions at the community level, further advancing the goal of improving maternal health in Ghana.
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